串聯臨床、數據與研究
合作洽詢聯絡我們
← 返回研究成果

RESEARCH PUBLICATION / 2025

通信 · Correspondence / Letter

Correspondence: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study.

Pharmacological research

論文與作者

Pharmacol Res. 2025;213:107639.

Chang-Yuan Hsu; Che-Wei Chang; Su-Boon Yong; Chin-Yuan Yii

摘要與原文

目前公開索引未提供摘要,請參閱期刊原文。

前往期刊頁面